Donor screening algorithm for exclusion of thrombophilia during evaluation of living donor liver transplantation

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages 277-282

  Ogawa, Hayato ^a   Fujimoto, Yasuhiro ^a   Yamamoto, Koji ^a   Hata, Taigo ^a   Nagai, Shunji ^a   Kamei, Hideya ^a   Arikawa, Takashi ^a   Nakamura, Taro ^a   Kiuchi, Tetsuya ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Deep vein thrombosis; LDLT; Liver transplantation; Living donor; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; BETA2 GLYCOPROTEIN 1 ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S;

ADULT; ALGORITHM; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SAFETY; SCREENING TEST; THROMBOPHILIA;

ADULT; ALGORITHMS; ANTITHROMBIN III; BETA 2-GLYCOPROTEIN I; DONOR SELECTION; FEMALE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROTEIN C; PROTEIN S; THROMBOPHILIA; YOUNG ADULT;

EID: 79953327493     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01216.x     Document Type: Article

References (23)

1. Wakeno-Takahashi M, Nakao S, Ikeda S et al. A case of suspected severe pulmonary embolism in a living-related liver transplantation donor. J Clin Anesth 2005: 17: 218.
2. Kitai T, Higashiyama H, Takada Y et al. Pulmonary embolism in a donor of living-related liver transplantation: estimation of donor's operative risk. Surgery 1996: 120: 570.
3. Durand F, Ettorre GM, Douard R et al. Donor safety in living related liver transplantation: underestimation of the risks for deep vein thrombosis and pulmonary embolism. Liver Transpl 2002: 8: 118.
4. Kinoshita S, Iida H, Inoue S et al. Protein S and protein C gene mutations in Japanese deep vein thrombosis patients. Clin Biochem 2005: 38: 908.
5. Miyata T, Kimura R, Kokubo Y, Sakata T. Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation. Int J Hematol 2006: 83: 217.
6. Sanson BJ, Simioni P, Tormene D et al. The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. Blood 1999: 94: 3702.
7. Tait RC, Walker ID, Reitsma PH et al. Prevalence of protein C deficiency in the healthy population. Thromb Haemost 1995: 73: 87.
8. Dykes AC, Walker ID, McMahon AD, Islam SI, Tait RC. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 2001: 113: 636.
9. Tait RC, Walker ID, Perry DJ et al. Prevalence of antithrombin deficiency in the healthy population. Br J Haematol 1994: 87: 106.
10. Petri M. Epidemiology of the antiphospholipid antibody syndrome. J Autoimmun 2000: 15: 145.
11. Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004: 126(3 Suppl.): 338S.
12. Wu O, Robertson L, Twaddle S et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess 2006: 10: 1.
13. Dondero F, Taille C, Mal H et al. Respiratory complications: a major concern after right hepatectomy in living liver donors. Transplantation 2006: 81: 181.
14. Kottke-Marchant K, Comp P. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. Arch Pathol Lab Med 2002: 126: 1337.
15. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med 2002: 126: 1326.
16. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001: 344: 1222.
17. Corral J, Hernandez-Espinosa D, Soria JM et al. Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis. Blood 2007: 109: 4258.
18. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003: 101: 1827.
19. Lambing A, Kuriakose P, Abouljoud MS. Hypercoagulability risks among adult living liver donors. Transplant Proc 2006: 38: 3579.
20. Cerutti E, Stratta C, Romagnoli R et al. Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl 2004: 10: 289.
21. Hata T, Fujimoto Y, Suzuki K et al. Two cases of central venous catheter-related thrombosis in living liver donors: how can the risk be minimized? Clin Transplant 2009: 23: 289.
22. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000: 85: 1334.
23. Kimura R, Honda S, Kawasaki T et al. Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients. Blood 2006: 107: 1737.